Library

Hüdromorfoon

Hydromorphone is a semisynthetic opioid of the morphinan class, derived as a hydrogenated ketone of morphine. First introduced to the mass market in 1926 under the brand name Dilaudid, it is prescribed for the management of moderate to severe pain. Hydromorphone is notably more potent than morphine and carries a high potential for addiction and dependence. It has low oral bioavailability and is most commonly administered intravenously in clinical settings.

Hüdromorfoon molecular structure
Hüdromorfoon molecular structure diagram from the DrugsPRO substance library.

Also known as: Exalgo, Dilaudid, Jurnista, Diluadid, Palladone, Hydromorph-Contin, Dimorphone, Dihydromorphinone, Hydromorphonum, Hidromorfona, Idromorfone

Classification

  • Chemical: Medicine
  • Chemical: Morphinan
  • Chemical: Opioid
  • Psychoactive: Depressant
  • Tag: Habit-Forming
  • Tag: Sedative
  • Tag: substituted morphinan

Effects

  • Pain Relief
  • Cough Suppression
  • Respiratory Depression
  • Pupil Constriction
  • Decreased Blood Pressure
  • Decreased Heart Rate
  • Euphoria
  • Thought Deceleration
  • Cognitive Fatigue
  • Dizziness
  • Mood Lift
  • Anxiety Suppression
  • Cognitive Dysphoria
  • Auditory Enhancement
  • Brightness Enhancement
  • Increased Music Appreciation
  • Dulled Perception
  • Decreased Libido

Routes of Administration

Oral

Dosage

  • Heavy: 8+ mg
  • Light: 0.5 – 2 mg
  • Common: 2 – 4 mg
  • Strong: 4 – 8 mg
  • Threshold: 0.5 mg

Duration

  • Onset: 0.25-0.5 h
  • Comeup: 1-2 h
  • Peak: 0.25-0.33 h
  • Offset: 0.5-1 h
  • After Effects: 1-12 h
  • Total Duration: 3-6 h

Insufflated

Dosage

  • Heavy: 8+ mg
  • Light: 1 – 2 mg
  • Common: 2 – 4 mg
  • Strong: 4 – 8 mg
  • Threshold: 0.5 mg

Duration

  • Onset: 0.08-0.25 h
  • Comeup: 0.1-0.2 h
  • Peak: 0.25-0.75 h
  • Offset: 0.25-0.5 h
  • After Effects: 3.5-6 h
  • Total Duration: 3-5 h

Intravenous

Dosage

  • Heavy: 6+ mg
  • Light: 1 – 2 mg
  • Common: 2 – 4 mg
  • Strong: 4 – 6 mg
  • Threshold: 0.2 mg

Duration

  • Onset: 0.07-0.08 h
  • Comeup: 0.17-0.33 h
  • Peak: 0.17-0.33 h
  • Offset: 1.5-3 h
  • After Effects: 1-2 h
  • Total Duration: 2-4 h

Rectal

Dosage

  • Heavy: 6+ mg
  • Light: 1–2 mg
  • Common: 2–4 mg
  • Strong: 4–6 mg
  • Threshold: 0.5 mg

Duration

No data available for this section yet.

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu

Hydromorphone - DrugsPRO ainejuhend

Hydromorphone: Hydromorphone is a semisynthetic opioid of the morphinan class, derived as a hydrogenated ketone of morphine. First introduced to the mass market in 1926 under the brand name Dilaudid, it is prescribed for the management of moderate to severe pain. Hydromorphone is notably more potent

Related pages